Aquarius provides update on expected delay in filing annual financial results for the year ended March 31, 2021


TORONTO, ON / ACCESS WIRE /July 20, 2021 /Aquarius Surgical Technologies Inc. (CSE:ASTI) (the “Company”) announces an update to the press release issued on July 19, 2021, when it announced that there was an expected delay in filing annual financial results for the year ended March 31 2021, and that an application was underway to the Ontario Securities Commission for a cease-trading order by management in accordance with National Policy 12-203.

The Company has been advised by the Ontario Securities Commission that a management ceasefire order will not be issued and unless the annual audited financial statements, MD&A and certificates of the Chief Executive Officer and Chief Financial Officer for the year ended March 31, 2021 (the “annual filings”) are not filed until July 29, 2021 (the “Regulatory Filing Deadline”), so an order is The trade ban will be issued.

Although the Company expects that it will not be able to complete the filing of annual documents before the regulatory filing deadline, it continues to work closely with its auditors to complete the review and assessments. necessary, in order to file the annual documents at the latest first opportunity.

If the annual filings cannot be completed by the regulatory filing deadline, the Company will not be able to file the unaudited interim financial statements, MD&A and related CEO and CEO certificates. finances for the first quarter ended June 30, 2021 (the “Deposits”), which must be deposited by August 30, 2021, and the filing of Intermediate Deposits will therefore be delayed until the Annual Deposits have been completed.

About Aquarius Surgical Technologies Inc.

Aquarius Surgical Technologies is an exclusive supplier of innovative and minimally invasive medical laser systems and consumables for multiple medical disciplines, primarily in the field of urology. The solutions also include clinical training, service, support and maintenance. ASTI is focused on increasing the availability of services for patients, improving the quality of patient care, improving operational efficiency and reducing total operational costs.

For more information please contact:

Lorne MacFarlane, Chief Financial Officer [email protected]

Neither the Canadian Securities Exchange nor its Regulation Services Provider (as that term is defined in the policies of the Canadian Securities Exchange) accepts responsibility for the adequacy or accuracy of this release..

SOURCE: Aquarius Surgical Technologies Inc.

See the source version on 31-2021

Leave A Reply

Your email address will not be published.